Lupin board of directors has approved the appointment of Vinita Gupta as Chief Executive Officer and Nilesh D. Gupta as Managing Director from September 2013. Vinita and Nilesh are children of Dr. Desh Bandhu Gupta, Lupin’s Founder and Chairman. Kamal K. Sharma, present the company’s Managing Director would move up as Vice-Chairman.
Vinita Gupta, has earlier been the Chief Executive Officer, Group President and Managing Director of Lupin Pharmaceuticals Inc. USA. She has been looking after the USA business of the company since 2003. She is a pharmacy graduate from the University of Mumbai and an from the J. L. Kellogg Graduate School of Management, USA.
Nilesh D. Gupta has been Group President of Lupin Ltd. since July 1, 2006 and served as its President of Advanced Markets. He is a Chemical Engineer from the University Department of Chemical Technology (UDCT), Mumbai., and has studied Healthcare, Strategic Management and Finance at the Wharton School, University of Pennsylvania, USA.
Lupin , was set up in 1968 and first gained recognition when it became one of the world’s largest manufacturers of Tuberculosis drugs. Recently, Lupin also has also gained the unique distinction of being the fastest growing top 10 Generics players in the two largest pharmaceutical markets of the world – The U.S and Japan.